Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis

Claudia Vener, Andrea Guffanti, Mauro Pomati, Mariangela Colombi, Alessandra Aliettt, Maria Luisa La Targia, Fabrizia Bamonti-Catena, Luca Baldini

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The serum levels of some cytokines seem to correlate with outcome in Hodgkin's disease (HD) and may be helpful in formulating new and better prognostic systems. The aim of this study was to analyse the correlations between the serum levels of different cytokines and the clinico-hematological features suggestive of a worse prognosis. The study involved 31 pts with a 'de novo' diagnosis of HD (median age: 30 yrs; M/F: 13/18; stage I/II vs III/IV: 19/12; B symptoms: 12; bulky disease and extranodal disease: 9). The serum levels of sCD30, TNFα, TNF receptor I and II, IL6, IL6 receptor, IL10, sICAM-1 were evaluated at diagnosis, and correlated with gender, age (≤/> 30), stage (I-II vs III-IV), systemic symptoms, bulky disease, ESR ( 170 μg/dL), WBC counts (≤/> 15 x 10 9/L), prognostic scores (PS) according to Hasenclever ( 33.15 U/mL, TNFα > 29.71 pg/mL, IL6 > 12.43 pg/mL, TNF-RI > 3.23 ng/mL, IL6-R > 57 ng/mL) that significantly correlate with systemic symptoms, higher disease stages, ESR, serum copper, WBC counts and PS. Our study shows that high sCD30, TNFα, IL6 and TNF-RI levels are associated with advanced disease or a worse prognostic score. In the context of multiparametric HD staging, cytokine evaluation may be useful for identifying candidates for more intensive therapies.

Original languageEnglish
Pages (from-to)333-339
Number of pages7
JournalLeukemia and Lymphoma
Volume37
Issue number3-4
Publication statusPublished - 2000

Fingerprint

Hodgkin Disease
Cytokines
Interleukin-6
Serum
Interleukin-6 Receptors
Tumor Necrosis Factor Receptors
Interleukin-10
Copper
Therapeutics

Keywords

  • Advanced disease
  • Hodgkin's disease
  • Serum cytokines
  • Worse prognosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis. / Vener, Claudia; Guffanti, Andrea; Pomati, Mauro; Colombi, Mariangela; Aliettt, Alessandra; Targia, Maria Luisa La; Bamonti-Catena, Fabrizia; Baldini, Luca.

In: Leukemia and Lymphoma, Vol. 37, No. 3-4, 2000, p. 333-339.

Research output: Contribution to journalArticle

Vener, C, Guffanti, A, Pomati, M, Colombi, M, Aliettt, A, Targia, MLL, Bamonti-Catena, F & Baldini, L 2000, 'Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis', Leukemia and Lymphoma, vol. 37, no. 3-4, pp. 333-339.
Vener, Claudia ; Guffanti, Andrea ; Pomati, Mauro ; Colombi, Mariangela ; Aliettt, Alessandra ; Targia, Maria Luisa La ; Bamonti-Catena, Fabrizia ; Baldini, Luca. / Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis. In: Leukemia and Lymphoma. 2000 ; Vol. 37, No. 3-4. pp. 333-339.
@article{dcdd60237bb84abd9fcdd6efae970538,
title = "Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis",
abstract = "The serum levels of some cytokines seem to correlate with outcome in Hodgkin's disease (HD) and may be helpful in formulating new and better prognostic systems. The aim of this study was to analyse the correlations between the serum levels of different cytokines and the clinico-hematological features suggestive of a worse prognosis. The study involved 31 pts with a 'de novo' diagnosis of HD (median age: 30 yrs; M/F: 13/18; stage I/II vs III/IV: 19/12; B symptoms: 12; bulky disease and extranodal disease: 9). The serum levels of sCD30, TNFα, TNF receptor I and II, IL6, IL6 receptor, IL10, sICAM-1 were evaluated at diagnosis, and correlated with gender, age (≤/> 30), stage (I-II vs III-IV), systemic symptoms, bulky disease, ESR ( 170 μg/dL), WBC counts (≤/> 15 x 10 9/L), prognostic scores (PS) according to Hasenclever ( 33.15 U/mL, TNFα > 29.71 pg/mL, IL6 > 12.43 pg/mL, TNF-RI > 3.23 ng/mL, IL6-R > 57 ng/mL) that significantly correlate with systemic symptoms, higher disease stages, ESR, serum copper, WBC counts and PS. Our study shows that high sCD30, TNFα, IL6 and TNF-RI levels are associated with advanced disease or a worse prognostic score. In the context of multiparametric HD staging, cytokine evaluation may be useful for identifying candidates for more intensive therapies.",
keywords = "Advanced disease, Hodgkin's disease, Serum cytokines, Worse prognosis",
author = "Claudia Vener and Andrea Guffanti and Mauro Pomati and Mariangela Colombi and Alessandra Aliettt and Targia, {Maria Luisa La} and Fabrizia Bamonti-Catena and Luca Baldini",
year = "2000",
language = "English",
volume = "37",
pages = "333--339",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "3-4",

}

TY - JOUR

T1 - Soluble cytokine levels correlate with the activity and clinical stage of Hodgkin's disease at diagnosis

AU - Vener, Claudia

AU - Guffanti, Andrea

AU - Pomati, Mauro

AU - Colombi, Mariangela

AU - Aliettt, Alessandra

AU - Targia, Maria Luisa La

AU - Bamonti-Catena, Fabrizia

AU - Baldini, Luca

PY - 2000

Y1 - 2000

N2 - The serum levels of some cytokines seem to correlate with outcome in Hodgkin's disease (HD) and may be helpful in formulating new and better prognostic systems. The aim of this study was to analyse the correlations between the serum levels of different cytokines and the clinico-hematological features suggestive of a worse prognosis. The study involved 31 pts with a 'de novo' diagnosis of HD (median age: 30 yrs; M/F: 13/18; stage I/II vs III/IV: 19/12; B symptoms: 12; bulky disease and extranodal disease: 9). The serum levels of sCD30, TNFα, TNF receptor I and II, IL6, IL6 receptor, IL10, sICAM-1 were evaluated at diagnosis, and correlated with gender, age (≤/> 30), stage (I-II vs III-IV), systemic symptoms, bulky disease, ESR ( 170 μg/dL), WBC counts (≤/> 15 x 10 9/L), prognostic scores (PS) according to Hasenclever ( 33.15 U/mL, TNFα > 29.71 pg/mL, IL6 > 12.43 pg/mL, TNF-RI > 3.23 ng/mL, IL6-R > 57 ng/mL) that significantly correlate with systemic symptoms, higher disease stages, ESR, serum copper, WBC counts and PS. Our study shows that high sCD30, TNFα, IL6 and TNF-RI levels are associated with advanced disease or a worse prognostic score. In the context of multiparametric HD staging, cytokine evaluation may be useful for identifying candidates for more intensive therapies.

AB - The serum levels of some cytokines seem to correlate with outcome in Hodgkin's disease (HD) and may be helpful in formulating new and better prognostic systems. The aim of this study was to analyse the correlations between the serum levels of different cytokines and the clinico-hematological features suggestive of a worse prognosis. The study involved 31 pts with a 'de novo' diagnosis of HD (median age: 30 yrs; M/F: 13/18; stage I/II vs III/IV: 19/12; B symptoms: 12; bulky disease and extranodal disease: 9). The serum levels of sCD30, TNFα, TNF receptor I and II, IL6, IL6 receptor, IL10, sICAM-1 were evaluated at diagnosis, and correlated with gender, age (≤/> 30), stage (I-II vs III-IV), systemic symptoms, bulky disease, ESR ( 170 μg/dL), WBC counts (≤/> 15 x 10 9/L), prognostic scores (PS) according to Hasenclever ( 33.15 U/mL, TNFα > 29.71 pg/mL, IL6 > 12.43 pg/mL, TNF-RI > 3.23 ng/mL, IL6-R > 57 ng/mL) that significantly correlate with systemic symptoms, higher disease stages, ESR, serum copper, WBC counts and PS. Our study shows that high sCD30, TNFα, IL6 and TNF-RI levels are associated with advanced disease or a worse prognostic score. In the context of multiparametric HD staging, cytokine evaluation may be useful for identifying candidates for more intensive therapies.

KW - Advanced disease

KW - Hodgkin's disease

KW - Serum cytokines

KW - Worse prognosis

UR - http://www.scopus.com/inward/record.url?scp=0034107973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034107973&partnerID=8YFLogxK

M3 - Article

VL - 37

SP - 333

EP - 339

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3-4

ER -